GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...

Check out our RILY stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.

Check out our PARA stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.